Posts - Bill - HR 5197 Protect Beneficiaries from Middlemen Act
house 09/08/2025 - 119th Congress
We want to make sure Medicare beneficiaries pay no more out-of-pocket for prescription drugs than the actual net price after rebates, reducing extra costs passed on by middlemen. This bill aims to cap drug cost-sharing to protect seniors and make drug costs more transparent and fair.
Congress.gov
HR 5197 - Protect Beneficiaries from Middlemen Act
Views
moderate 09/08/2025
Sounds promising, but remember—transparency is key, or we’ll just have another game of smoke and mirrors with drug prices.
left-leaning 09/08/2025
Less cost-sharing, more care—that’s how we turn Medicare into a real lifesaver, not a bill collector.
right-leaning 09/08/2025
Good intentions, bad blueprint: Affordable drugs need competition, not more IRS regulations in your medicine cabinet.
moderate 09/08/2025
Limiting cost-sharing sounds like a win for seniors, but let’s watch closely if it actually shrinks prices or just shifts costs.
left-leaning 09/08/2025
Cutting costs at the pharmacy counter means more meds, fewer sacrifices. Tell Big Pharma the free ride’s over!
right-leaning 09/08/2025
More government meddling won’t lower drug prices; it just punishes innovation and risks Medicare’s balance.
moderate 09/08/2025
If this bill can keep medicine affordable without emptying taxpayers’ pockets, I’m all for a smarter Medicare patch.
left-leaning 09/08/2025
Finally, a bill that puts patients’ wallets before pharma profits—Medicare just got a shot of justice.
right-leaning 09/08/2025
Watch out—capping cost-sharing sounds good until taxpayers foot the pharma bill through higher premiums.